ChromaDex Sets Second Quarter 2018 Financial Results on Thursday, August 9, 2018
August 02, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
Fourth Published Clinical Trial Confirms Long-Term Safety of NIAGEN® Supplementation at High Doses and Shows Potential for Improvement in Liver Health
July 11, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that...
TRU NIAGEN® to be featured at the American Association of Naturopathic Physicians Annual Convention and the 2018 Healthy Aging Summit
July 09, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex added to membership of US small-cap Russell 2000® Index
June 25, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
ChromaDex Appoints Lisa Bratkovich as Chief Marketing Officer
June 04, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
TRU NIAGEN® to be featured at the American Society for Nutrition's Annual Meeting
May 29, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board
May 14, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex Corporation Reports First Quarter 2018 Financial Results
May 10, 2018 16:05 ET
|
ChromaDex Corporation
IRVINE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to improving the way people age, announced today first...
ChromaDex Sets First Quarter 2018 Financial Results on Thursday, May 10, 2018
May 03, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, will report financial...
ChromaDex Remains Confident Amidst Inter Partes Review (IPR) Procedural Changes
May 01, 2018 06:30 ET
|
ChromaDex Corporation
IRVINE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that the...